<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-26008" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Nuclear Medicine Liver/Spleen Test</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Willyard</surname>
            <given-names>Charles E.</given-names>
          </name>
          <aff>University of Nevada, Reno</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kalathil</surname>
            <given-names>Sumodh C.</given-names>
          </name>
          <aff>UNR school of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Charles Willyard declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sumodh Kalathil declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-26008.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The nuclear medicine liver/spleen test is a non-invasive nuclear medicine imaging study used to assess a patient&#x02019;s liver and spleen. In the liver/spleen scan, a radioactive tracer&#x02014;classically technetium-99m sulfur-colloid&#x02014;is injected into a patient&#x02019;s veins to characterize the anatomy and functional status of the liver and spleen.</p>
        <p>The liver-spleen test can indicate functional abnormalities of the liver and spleen based upon the amount and location of the radioactive tracer that is phagocytized by each organ&#x02019;s phagocytic cells. The liver/spleen scan was utilized more frequently before the widespread adoption of CT, ultrasound, and MRI to assess the severity of liver damage in patients with cirrhosis, elevated liver enzymes, and to diagnose conditions such as focal nodular hyperplasia and assess splenic injury in trauma patients.<xref ref-type="bibr" rid="article-26008.r1">[1]</xref><xref ref-type="bibr" rid="article-26008.r2">[2]</xref><xref ref-type="bibr" rid="article-26008.r3">[3]</xref></p>
      </sec>
      <sec id="article-26008.s2" sec-type="Specimen Collection">
        <title>Specimen Collection</title>
        <p>Tc-99m sulfur colloid is injected through the veins and is subsequently taken up by the mononuclear phagocyte system (aka reticuloendothelial system) of the patient&#x02019;s liver, spleen, and bone marrow.<xref ref-type="bibr" rid="article-26008.r4">[4]</xref>&#x000a0;The technician takes planar computerized images are using a scintillation gamma camera with the patient in various anatomical positions. The interpreter of the test then compares the amount of Tc-99m sulfur colloid phagocytosed by the liver&#x02019;s Kupffer cells to the amount of Tc-99m colloid phagocytosed by the spleen and bone marrow. A decrease in Tc-99m colloid uptake by the liver&#x02019;s Kupffer cells along with an increase in uptake by the spleen and bone marrow is known as the &#x0201c;colloid shift.&#x0201d; These findings indicate damage to the phagocytic components of the liver and represent an increase in uptake by the spleen and bone marrow.<xref ref-type="bibr" rid="article-26008.r5">[5]</xref>&#x000a0;Areas with decreased uptake appear dark or non-existent on the scan while areas of increased uptake appear bright. This planar imaging provides a qualitative view of the function of the liver and spleen.</p>
        <p>In recent years, attenuation-corrected single-photon emission computerized tomography (SPECT) scanning has led to the ability to quantitate uptake in the spleen and liver. SPECT scanning also provides three-dimensional images of the liver and spleen.</p>
      </sec>
      <sec id="article-26008.s3" sec-type="Procedures">
        <title>Procedures</title>
        <p>The procedure may take approximately 45 minutes to complete. After obtaining written and verbal consent, the patient is accompanied to the radiology suite, and a peripheral IV is placed in the patient&#x02019;s arm. Radioactive Tc-99m tracer is then injected into the patient&#x02019;s veins. After approximately 10 to 15 minutes, a scintillation gamma camera takes images while the patient is placed in various positions. The patient is asked to lay in the anterior, posterior, and oblique right positions as images are taken of the patient&#x02019;s liver.<xref ref-type="bibr" rid="article-26008.r4">[4]</xref>&#x000a0;</p>
        <p>Left-sided images are taken to evaluate the patient&#x02019;s spleen.<xref ref-type="bibr" rid="article-26008.r4">[4]</xref>&#x000a0;The patient is asked to lay still with minimal movement throughout the procedure, except when repositioned. SPECT/CT may be performed following the liver/spleen scan. SPECT/CT generally takes an additional 15 to 20 minutes to perform. Once the images are obtained, and the scan is complete, the peripheral IV is removed, and the patient is allowed to leave the radiology suite.</p>
      </sec>
      <sec id="article-26008.s4" sec-type="Indications">
        <title>Indications</title>
        <p>The liver/spleen test has declined in use in recent years with the advent of CT and ultrasound imaging. However, the test remains a useful modality for evaluating underlying space-occupying lesions and assessing for liver damage.<xref ref-type="bibr" rid="article-26008.r5">[5]</xref>&#x000a0;The liver/spleen can also be used to obtain a general overview of the functional status of the reticuloendothelial systems of the liver and spleen. Liver/spleen scans can also be used to help detect hemangiomas and may be indicated in patients who cannot undergo an MRI or CT scan.<xref ref-type="bibr" rid="article-26008.r5">[5]</xref></p>
      </sec>
      <sec id="article-26008.s5" sec-type="Potential Diagnosis">
        <title>Potential Diagnosis</title>
        <p>In addition to assessing the functional status of the reticuloendothelial systems of the liver and spleen, the liver/spleen scan may aid in the diagnosis of the following conditions:</p>
        <list list-type="bullet">
          <list-item>
            <p>Liver damage from cirrhosis<xref ref-type="bibr" rid="article-26008.r1">[1]</xref></p>
          </list-item>
          <list-item>
            <p>Splenic injury/infarction in trauma patients<xref ref-type="bibr" rid="article-26008.r3">[3]</xref></p>
          </list-item>
          <list-item>
            <p>Hepatic hemangiomas<xref ref-type="bibr" rid="article-26008.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Hepatic cysts</p>
          </list-item>
          <list-item>
            <p>Hepatic abscesses</p>
          </list-item>
          <list-item>
            <p>Splenic infarction in patients with cirrhosis<xref ref-type="bibr" rid="article-26008.r6">[6]</xref></p>
          </list-item>
          <list-item>
            <p>Functional hyposplenism in patients with amyloidosis<xref ref-type="bibr" rid="article-26008.r7">[7]</xref></p>
          </list-item>
          <list-item>
            <p>Budd-Chiari syndrome (due to classic decrease in uptake in the left and right lobes of the liver)<xref ref-type="bibr" rid="article-26008.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Thrombocytopenia following splenectomy in patients who may have accessory spleens<xref ref-type="bibr" rid="article-26008.r8">[8]</xref></p>
          </list-item>
          <list-item>
            <p>Evaluation of liver and spleen involvement in patients with Gaucher disease<xref ref-type="bibr" rid="article-26008.r9">[9]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26008.s6" sec-type="Normal and Critical Findings">
        <title>Normal and Critical Findings</title>
        <p>Normal findings would include imaging consistent with normal hepatic and splenic uptake by their respective reticuloendothelial systems. The distribution of colloid in the liver and spleen would not be markedly different on imaging. Critical findings would include decreased uptake by the liver&#x02019;s Kupffer cells paired with increased uptake by the spleen, indicating functional damage to the liver&#x02019;s reticuloendothelial system. In patients with splenic infarction secondary to cirrhosis and portal hypertension, liver/spleen scan may often show areas of diminished uptake of Tc-99m in the spleen.<xref ref-type="bibr" rid="article-26008.r6">[6]</xref>&#x000a0;Similarly, decreased uptake by the spleen in a trauma patient may indicate damage to the spleen.&#x000a0;</p>
      </sec>
      <sec id="article-26008.s7" sec-type="Interfering Factors">
        <title>Interfering Factors</title>
        <p>There are few interfering factors in performing the liver/spleen test. They include retained dye from previous nuclear medicine studies. There may also be increased uptake of Tc-99m tracer in organs other than the liver and spleen, particularly in the lungs.</p>
      </sec>
      <sec id="article-26008.s8" sec-type="Complications">
        <title>Complications</title>
        <p>The liver/spleen test is a relatively safe procedure. Complications are rare and include allergic reaction to the radioactive tracer. Exposure to ionizing radiation is also a risk that requires an assessment before performing the liver/spleen test. Patients who are pregnant should avoid the procedure due to radiation exposure. Tc-99m sulfur colloid has a half-life of approximately six hours. The complete effects of Tc-99m sulfur colloid on the breastfeeding child are not fully understood. Radioactivity in the mother&#x02019;s breast milk is unlikely to be in the same form as in the adult patient.<xref ref-type="bibr" rid="article-26008.r10">[10]</xref>&#x000a0;In general, patients who are breastfeeding should avoid breastfeeding for approximately 72 hours following the liver/spleen test.</p>
      </sec>
      <sec id="article-26008.s9" sec-type="Patient Safety and Education">
        <title>Patient Safety and Education</title>
        <p>Patients who are pregnant or allergic to the Tc-99m radioactive tracer should not undergo a liver/spleen test. The risks - particularly of exposure to ionizing radiation - benefits, and alternatives to the liver/spleen scan, should be explained in layman&#x02019;s terms to the patient. Informed and written consent should then be obtained from the patient or the patient&#x02019;s surrogate decision-maker.</p>
        <p>There is no specific prep for the test. A time-out including the patient&#x02019;s name, date-of-birth, description of the procedure being performed, medications, and allergies should be completed before the start of the procedure. The patient should be informed before the study of the need to inject radioactive tracer and to lay still during the study. The minimum possible amount of radioactive tracer should be injected into the patient&#x02019;s veins to limit the patient&#x02019;s exposure to radiation.</p>
      </sec>
      <sec id="article-26008.s10" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>While the nuclear medicine liver/spleen test has fallen out of favor with the advent of CT, MRI, and ultrasound imaging, there are still advantages to this nuclear medicine test. The liver/spleen scan is a relatively low-cost nuclear medicine procedure. It may also be used to diagnose patients with hepatic vascular disorders such as Budd-Chiari syndrome who are unable to receive IV contrast for CT or MRI. For Budd-Chiari syndrome, in particular, Doppler ultrasonography can be used to confirm the diagnosis. There has been renewed interest in the liver/spleen test - primarily as it is used in conjunction with attenuation-corrected SPECT scanning. More recently, Tc-99m liver/spleen scans have been shown to demonstrate functional hyposplenism in renal transplant recipients.<xref ref-type="bibr" rid="article-26008.r11">[11]</xref>&#x000a0;</p>
        <p>The liver-spleen scan, when combined with attenuation-corrected SPECT, can be used to map the function of different regions of the liver and spleen non-invasively.<xref ref-type="bibr" rid="article-26008.r12">[12]</xref>&#x000a0;A study of patients with hepatocellular carcinoma showed a correlation between Sulfur-Colloid SPECT/CT uptake and clinical liver function.<xref ref-type="bibr" rid="article-26008.r13">[13]</xref>&#x000a0;Performing planar liver-spleen scanning before attenuation-corrected SPECT ensures that the patient has normal colloid distribution within the liver. solid lipid nanoparticles (SLNs) labeled with Tc-99m have also been investigated recently for use in liver/spleen tests as an alternative to sulfur-colloid.<xref ref-type="bibr" rid="article-26008.r14">[14]</xref>&#x000a0;</p>
        <p>The nuclear medicine liver/spleen&#x000a0;test is a useful imaging modality that complements modern imaging techniques. Clinicians should consider the nuclear medicine liver/spleen test when choosing an imaging study.</p>
      </sec>
      <sec id="article-26008.s11">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26008&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26008">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/26008/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=26008">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-26008.s12">
        <title>References</title>
        <ref id="article-26008.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rogers</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Mack</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Freeny</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Sones</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Hepatic focal nodular hyperplasia: angiography, CT, sonography, and scintigraphy.</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>1981</year>
            <month>Nov</month>
            <volume>137</volume>
            <issue>5</issue>
            <fpage>983</fpage>
            <page-range>983-90</page-range>
            <pub-id pub-id-type="pmid">6975026</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26008.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoefs</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kanel</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Braunstein</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>The liver-spleen scan as a quantitative liver function test: correlation with liver severity at peritoneoscopy.</article-title>
            <source>Hepatology</source>
            <year>1995</year>
            <month>Oct</month>
            <volume>22</volume>
            <issue>4 Pt 1</issue>
            <fpage>1113</fpage>
            <page-range>1113-21</page-range>
            <pub-id pub-id-type="pmid">7557859</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26008.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Kajubi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Colloid shift in technetium-99m sulfur colloid liver-spleen scans of trauma patients.</article-title>
            <source>Clin Nucl Med</source>
            <year>1987</year>
            <month>Oct</month>
            <volume>12</volume>
            <issue>10</issue>
            <fpage>801</fpage>
            <page-range>801-4</page-range>
            <pub-id pub-id-type="pmid">3677523</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26008.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Royal</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Drum</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Nagle</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Sylvester</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Ziessman</surname>
                <given-names>HA</given-names>
              </name>
            </person-group>
            <article-title>Procedure guideline for hepatic and splenic imaging. Society of Nuclear Medicine.</article-title>
            <source>J Nucl Med</source>
            <year>1998</year>
            <month>Jun</month>
            <volume>39</volume>
            <issue>6</issue>
            <fpage>1114</fpage>
            <page-range>1114-6</page-range>
            <pub-id pub-id-type="pmid">9627356</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26008.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Middleton</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Strober</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Planar scintigraphic imaging of the gastrointestinal tract in clinical practice.</article-title>
            <source>Semin Nucl Med</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>42</volume>
            <issue>1</issue>
            <fpage>33</fpage>
            <page-range>33-40</page-range>
            <pub-id pub-id-type="pmid">22117811</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26008.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chin</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>McCormick</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Hilson</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Burroughs</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>McIntyre</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Liver/spleen scintigraphy for diagnosis of splenic infarction in cirrhotic patients.</article-title>
            <source>Postgrad Med J</source>
            <year>1993</year>
            <month>Sep</month>
            <volume>69</volume>
            <issue>815</issue>
            <fpage>715</fpage>
            <page-range>715-7</page-range>
            <pub-id pub-id-type="pmid">8255838</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26008.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Powsner</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Simms</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Chudnovsky</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>VW</given-names>
              </name>
              <name>
                <surname>Skinner</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Scintigraphic functional hyposplenism in amyloidosis.</article-title>
            <source>J Nucl Med</source>
            <year>1998</year>
            <month>Feb</month>
            <volume>39</volume>
            <issue>2</issue>
            <fpage>221</fpage>
            <page-range>221-3</page-range>
            <pub-id pub-id-type="pmid">9476921</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26008.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anand</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Munker</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Is a liver-spleen scan helpful in the evaluation of patients with thrombocytopenia?</article-title>
            <source>Ann Hematol</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>94</volume>
            <issue>11</issue>
            <fpage>1921</fpage>
            <page-range>1921-2</page-range>
            <pub-id pub-id-type="pmid">26174909</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26008.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Israel</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Jerushalmi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Front</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Scintigraphic findings in Gaucher's disease.</article-title>
            <source>J Nucl Med</source>
            <year>1986</year>
            <month>Oct</month>
            <volume>27</volume>
            <issue>10</issue>
            <fpage>1557</fpage>
            <page-range>1557-63</page-range>
            <pub-id pub-id-type="pmid">3760980</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26008.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stabin</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Breitz</surname>
                <given-names>HB</given-names>
              </name>
            </person-group>
            <article-title>Breast milk excretion of radiopharmaceuticals: mechanisms, findings, and radiation dosimetry.</article-title>
            <source>J Nucl Med</source>
            <year>2000</year>
            <month>May</month>
            <volume>41</volume>
            <issue>5</issue>
            <fpage>863</fpage>
            <page-range>863-73</page-range>
            <pub-id pub-id-type="pmid">10809203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26008.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ara&#x000fa;jo</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Neves</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Mandarim-de-Lacerda</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Orlando</surname>
                <given-names>MMC</given-names>
              </name>
            </person-group>
            <article-title>Assessment of Spleen Filtrate Function in Renal Transplant Recipients Using Technetium-99m Stannous Colloid Liver-Spleen Scan.</article-title>
            <source>Transplant Proc</source>
            <year>2017</year>
            <season>Jul-Aug</season>
            <volume>49</volume>
            <issue>6</issue>
            <fpage>1301</fpage>
            <page-range>1301-1306</page-range>
            <pub-id pub-id-type="pmid">28735998</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26008.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matesan</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Bowen</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Chapman</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Miyaoka</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Velez</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Wanner</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Nyflot</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Apisarnthanarax</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vesselle</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Assessment of functional liver reserve: old and new in 99mTc-sulfur colloid scintigraphy.</article-title>
            <source>Nucl Med Commun</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>38</volume>
            <issue>7</issue>
            <fpage>577</fpage>
            <page-range>577-586</page-range>
            <pub-id pub-id-type="pmid">28591006</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26008.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bowen</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Chapman</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Borgman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Miyaoka</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Kinahan</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Liou</surname>
                <given-names>IW</given-names>
              </name>
              <name>
                <surname>Sandison</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Vesselle</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Nyflot</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Apisarnthanarax</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Measuring total liver function on sulfur colloid SPECT/CT for improved risk stratification and outcome prediction of hepatocellular carcinoma patients.</article-title>
            <source>EJNMMI Res</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>57</fpage>
            <pub-id pub-id-type="pmid">27349530</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26008.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eroglu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yenilmez</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>An Investigation of the Usability of Solid Lipid Nanoparticles Radiolabelled with Tc-99m as Imaging Agents in Liver-Spleen Scintigraphy.</article-title>
            <source>J Biomed Nanotechnol</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>12</volume>
            <issue>7</issue>
            <fpage>1501</fpage>
            <page-range>1501-09</page-range>
            <pub-id pub-id-type="pmid">29337489</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
